UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $54
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $54.
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $54.